Beijing Tiantan Overview

  • Year Founded
  • 1919

Year Founded

  • Status
  • Public

  • Employees
  • 5,298

Employees

  • Stock Symbol
  • 600161

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $2.69
  • (As of Monday Closing)

Beijing Tiantan General Information

Description

Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business.

Contact Information

Website
www.btbp.com.cn
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 6, Boxing 2nd Road
  • Room 521, Building 8, Beijing Economic and Technological Development Zone
  • Beijing, 100024
  • China
+86 010
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Corporate Office
  • No. 6, Boxing 2nd Road
  • Room 521, Building 8, Beijing Economic and Technological Development Zone
  • Beijing, 100024
  • China
+86 010

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beijing Tiantan Stock Performance

As of 16-Jun-2025, Beijing Tiantan’s stock price is $2.69. Its current market cap is $5.31B with 1.98B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.69 $2.70 $2.57 - $3.93 $5.31B 1.98B 23.5M $0.10

Beijing Tiantan Financials Summary

As of 31-Mar-2025, Beijing Tiantan has a trailing 12-month revenue of $850M.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 5,625,149 5,330,596 6,902,891 5,437,767
Revenue 850,457 840,624 732,230 632,754
EBITDA 334,596 396,212 284,775 229,618
Net Income 204,942 215,898 156,877 130,806
Total Assets 2,235,103 2,173,877 2,001,532 1,873,974
Total Debt 17,817 7,372 5,977 58,437
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Beijing Tiantan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beijing Tiantan Acquisitions (1)

Beijing Tiantan’s most recent deal was a Merger/Acquisition with Xi'an Huitian Blood Products for . The deal was made on 06-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Xi'an Huitian Blood Products 06-Sep-2022 Merger/Acquisition Biotechnology
To view Beijing Tiantan’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Beijing Tiantan ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

31.05 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,673

Rank

Percentile

Pharmaceuticals

Industry

of 844

Rank

Percentile

Biotechnology

Subindustry

of 366

Rank

Percentile

To view Beijing Tiantan’s complete esg history, request access »

Beijing Tiantan FAQs

  • When was Beijing Tiantan founded?

    Beijing Tiantan was founded in 1919.

  • Where is Beijing Tiantan headquartered?

    Beijing Tiantan is headquartered in Beijing, China.

  • What is the size of Beijing Tiantan?

    Beijing Tiantan has 5,298 total employees.

  • What industry is Beijing Tiantan in?

    Beijing Tiantan’s primary industry is Drug Delivery.

  • Is Beijing Tiantan a private or public company?

    Beijing Tiantan is a Public company.

  • What is Beijing Tiantan’s stock symbol?

    The ticker symbol for Beijing Tiantan is 600161.

  • What is the current stock price of Beijing Tiantan?

    As of 16-Jun-2025 the stock price of Beijing Tiantan is $2.69.

  • What is the current market cap of Beijing Tiantan?

    The current market capitalization of Beijing Tiantan is $5.31B.

  • What is Beijing Tiantan’s current revenue?

    The trailing twelve month revenue for Beijing Tiantan is $850M.

  • What is Beijing Tiantan’s annual earnings per share (EPS)?

    Beijing Tiantan’s EPS for 12 months was $0.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »